Brucellosis Vaccines Market - Global Outlook and Forecast 2021-2027

January 2021 | 107 pages | ID: BC402994FB86EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Brucellosis Vaccines in global, including the following market information:
Global Brucellosis Vaccines Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Brucellosis Vaccines Market Sales, 2016-2021, 2022-2027, (M Doses)
Global top five Brucellosis Vaccines companies in 2020 (%)
The global Brucellosis Vaccines market was valued at 11 million in 2020 and is projected to reach US$ 13 million by 2027, at a CAGR of 3.5% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Brucellosis Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Brucellosis Vaccines Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Brucellosis Vaccines Market Segment Percentages, By Type, 2020 (%)

• S19 Vaccine
• RB51 Vaccine Strain
• Others

Global Brucellosis Vaccines Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Brucellosis Vaccines Market Segment Percentages, By Application, 2020 (%)

• Cattle
• Sheep
• Others

Global Brucellosis Vaccines Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Brucellosis Vaccines Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Brucellosis Vaccines revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Brucellosis Vaccines revenues share in global market, 2020 (%)
Key companies Brucellosis Vaccines sales in global market, 2016-2021 (Estimated), (M Doses)
Key companies Brucellosis Vaccines sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:

• Jinyu
• Colorado Serum
• Boehringer Ingelheim
• Biogenesis-Bago
• Vetal Company
• CZ Veterinaria
• SYVA Laboratorios
• Indian Immunologicals
• Qilu
• Tecnovax
• Hester Biosciences
• Zoetis
• Onderstepoort Biological
• Instituto Rosenbusch
• Ceva Sante Animale
• Calier & Biologicos Laverlam
• Biovet

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Brucellosis Vaccines Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Brucellosis Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BRUCELLOSIS VACCINES OVERALL MARKET SIZE

2.1 Global Brucellosis Vaccines Market Size: 2021 VS 2027
2.2 Global Brucellosis Vaccines Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Brucellosis Vaccines Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Brucellosis Vaccines Players in Global Market
3.2 Top Global Brucellosis Vaccines Companies Ranked by Revenue
3.3 Global Brucellosis Vaccines Revenue by Companies
3.4 Global Brucellosis Vaccines Sales by Companies
3.5 Global Brucellosis Vaccines Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Brucellosis Vaccines Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Brucellosis Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Brucellosis Vaccines Players in Global Market
  3.8.1 List of Global Tier 1 Brucellosis Vaccines Companies
  3.8.2 List of Global Tier 2 and Tier 3 Brucellosis Vaccines Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Brucellosis Vaccines Market Size Markets, 2021 & 2027
  4.1.2 S19 Vaccine
  4.1.3 RB51 Vaccine Strain
  4.1.4 Others
4.2 By Type - Global Brucellosis Vaccines Revenue & Forecasts
  4.2.1 By Type - Global Brucellosis Vaccines Revenue, 2016-2021
  4.2.2 By Type - Global Brucellosis Vaccines Revenue, 2022-2027
  4.2.3 By Type - Global Brucellosis Vaccines Revenue Market Share, 2016-2027
4.3 By Type - Global Brucellosis Vaccines Sales & Forecasts
  4.3.1 By Type - Global Brucellosis Vaccines Sales, 2016-2021
  4.3.2 By Type - Global Brucellosis Vaccines Sales, 2022-2027
  4.3.3 By Type - Global Brucellosis Vaccines Sales Market Share, 2016-2027
4.4 By Type - Global Brucellosis Vaccines Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Brucellosis Vaccines Market Size, 2021 & 2027
  5.1.2 Cattle
  5.1.3 Sheep
  5.1.4 Others
5.2 By Application - Global Brucellosis Vaccines Revenue & Forecasts
  5.2.1 By Application - Global Brucellosis Vaccines Revenue, 2016-2021
  5.2.2 By Application - Global Brucellosis Vaccines Revenue, 2022-2027
  5.2.3 By Application - Global Brucellosis Vaccines Revenue Market Share, 2016-2027
5.3 By Application - Global Brucellosis Vaccines Sales & Forecasts
  5.3.1 By Application - Global Brucellosis Vaccines Sales, 2016-2021
  5.3.2 By Application - Global Brucellosis Vaccines Sales, 2022-2027
  5.3.3 By Application - Global Brucellosis Vaccines Sales Market Share, 2016-2027
5.4 By Application - Global Brucellosis Vaccines Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Brucellosis Vaccines Market Size, 2021 & 2027
6.2 By Region - Global Brucellosis Vaccines Revenue & Forecasts
  6.2.1 By Region - Global Brucellosis Vaccines Revenue, 2016-2021
  6.2.2 By Region - Global Brucellosis Vaccines Revenue, 2022-2027
  6.2.3 By Region - Global Brucellosis Vaccines Revenue Market Share, 2016-2027
6.3 By Region - Global Brucellosis Vaccines Sales & Forecasts
  6.3.1 By Region - Global Brucellosis Vaccines Sales, 2016-2021
  6.3.2 By Region - Global Brucellosis Vaccines Sales, 2022-2027
  6.3.3 By Region - Global Brucellosis Vaccines Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Brucellosis Vaccines Revenue, 2016-2027
  6.4.2 By Country - North America Brucellosis Vaccines Sales, 2016-2027
  6.4.3 US Brucellosis Vaccines Market Size, 2016-2027
  6.4.4 Canada Brucellosis Vaccines Market Size, 2016-2027
  6.4.5 Mexico Brucellosis Vaccines Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Brucellosis Vaccines Revenue, 2016-2027
  6.5.2 By Country - Europe Brucellosis Vaccines Sales, 2016-2027
  6.5.3 Germany Brucellosis Vaccines Market Size, 2016-2027
  6.5.4 France Brucellosis Vaccines Market Size, 2016-2027
  6.5.5 U.K. Brucellosis Vaccines Market Size, 2016-2027
  6.5.6 Italy Brucellosis Vaccines Market Size, 2016-2027
  6.5.7 Russia Brucellosis Vaccines Market Size, 2016-2027
  6.5.8 Nordic Countries Brucellosis Vaccines Market Size, 2016-2027
  6.5.9 Benelux Brucellosis Vaccines Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Brucellosis Vaccines Revenue, 2016-2027
  6.6.2 By Region - Asia Brucellosis Vaccines Sales, 2016-2027
  6.6.3 China Brucellosis Vaccines Market Size, 2016-2027
  6.6.4 Japan Brucellosis Vaccines Market Size, 2016-2027
  6.6.5 South Korea Brucellosis Vaccines Market Size, 2016-2027
  6.6.6 Southeast Asia Brucellosis Vaccines Market Size, 2016-2027
  6.6.7 India Brucellosis Vaccines Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Brucellosis Vaccines Revenue, 2016-2027
  6.7.2 By Country - South America Brucellosis Vaccines Sales, 2016-2027
  6.7.3 Brazil Brucellosis Vaccines Market Size, 2016-2027
  6.7.4 Argentina Brucellosis Vaccines Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Brucellosis Vaccines Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Brucellosis Vaccines Sales, 2016-2027
  6.8.3 Turkey Brucellosis Vaccines Market Size, 2016-2027
  6.8.4 Israel Brucellosis Vaccines Market Size, 2016-2027
  6.8.5 Saudi Arabia Brucellosis Vaccines Market Size, 2016-2027
  6.8.6 UAE Brucellosis Vaccines Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 Jinyu
  7.1.1 Jinyu Corporate Summary
  7.1.2 Jinyu Business Overview
  7.1.3 Jinyu Brucellosis Vaccines Major Product Offerings
  7.1.4 Jinyu Brucellosis Vaccines Sales and Revenue in Global (2016-2021)
  7.1.5 Jinyu Key News
7.2 Colorado Serum
  7.2.1 Colorado Serum Corporate Summary
  7.2.2 Colorado Serum Business Overview
  7.2.3 Colorado Serum Brucellosis Vaccines Major Product Offerings
  7.2.4 Colorado Serum Brucellosis Vaccines Sales and Revenue in Global (2016-2021)
  7.2.5 Colorado Serum Key News
7.3 Boehringer Ingelheim
  7.3.1 Boehringer Ingelheim Corporate Summary
  7.3.2 Boehringer Ingelheim Business Overview
  7.3.3 Boehringer Ingelheim Brucellosis Vaccines Major Product Offerings
  7.3.4 Boehringer Ingelheim Brucellosis Vaccines Sales and Revenue in Global (2016-2021)
  7.3.5 Boehringer Ingelheim Key News
7.4 Biogenesis-Bago
  7.4.1 Biogenesis-Bago Corporate Summary
  7.4.2 Biogenesis-Bago Business Overview
  7.4.3 Biogenesis-Bago Brucellosis Vaccines Major Product Offerings
  7.4.4 Biogenesis-Bago Brucellosis Vaccines Sales and Revenue in Global (2016-2021)
  7.4.5 Biogenesis-Bago Key News
7.5 Vetal Company
  7.5.1 Vetal Company Corporate Summary
  7.5.2 Vetal Company Business Overview
  7.5.3 Vetal Company Brucellosis Vaccines Major Product Offerings
  7.5.4 Vetal Company Brucellosis Vaccines Sales and Revenue in Global (2016-2021)
  7.5.5 Vetal Company Key News
7.6 CZ Veterinaria
  7.6.1 CZ Veterinaria Corporate Summary
  7.6.2 CZ Veterinaria Business Overview
  7.6.3 CZ Veterinaria Brucellosis Vaccines Major Product Offerings
  7.6.4 CZ Veterinaria Brucellosis Vaccines Sales and Revenue in Global (2016-2021)
  7.6.5 CZ Veterinaria Key News
7.7 SYVA Laboratorios
  7.7.1 SYVA Laboratorios Corporate Summary
  7.7.2 SYVA Laboratorios Business Overview
  7.7.3 SYVA Laboratorios Brucellosis Vaccines Major Product Offerings
  7.4.4 SYVA Laboratorios Brucellosis Vaccines Sales and Revenue in Global (2016-2021)
  7.7.5 SYVA Laboratorios Key News
7.8 Indian Immunologicals
  7.8.1 Indian Immunologicals Corporate Summary
  7.8.2 Indian Immunologicals Business Overview
  7.8.3 Indian Immunologicals Brucellosis Vaccines Major Product Offerings
  7.8.4 Indian Immunologicals Brucellosis Vaccines Sales and Revenue in Global (2016-2021)
  7.8.5 Indian Immunologicals Key News
7.9 Qilu
  7.9.1 Qilu Corporate Summary
  7.9.2 Qilu Business Overview
  7.9.3 Qilu Brucellosis Vaccines Major Product Offerings
  7.9.4 Qilu Brucellosis Vaccines Sales and Revenue in Global (2016-2021)
  7.9.5 Qilu Key News
7.10 Tecnovax
  7.10.1 Tecnovax Corporate Summary
  7.10.2 Tecnovax Business Overview
  7.10.3 Tecnovax Brucellosis Vaccines Major Product Offerings
  7.10.4 Tecnovax Brucellosis Vaccines Sales and Revenue in Global (2016-2021)
  7.10.5 Tecnovax Key News
7.11 Hester Biosciences
  7.11.1 Hester Biosciences Corporate Summary
  7.11.2 Hester Biosciences Brucellosis Vaccines Business Overview
  7.11.3 Hester Biosciences Brucellosis Vaccines Major Product Offerings
  7.11.4 Hester Biosciences Brucellosis Vaccines Sales and Revenue in Global (2016-2021)
  7.11.5 Hester Biosciences Key News
7.12 Zoetis
  7.12.1 Zoetis Corporate Summary
  7.12.2 Zoetis Brucellosis Vaccines Business Overview
  7.12.3 Zoetis Brucellosis Vaccines Major Product Offerings
  7.12.4 Zoetis Brucellosis Vaccines Sales and Revenue in Global (2016-2021)
  7.12.5 Zoetis Key News
7.13 Onderstepoort Biological
  7.13.1 Onderstepoort Biological Corporate Summary
  7.13.2 Onderstepoort Biological Brucellosis Vaccines Business Overview
  7.13.3 Onderstepoort Biological Brucellosis Vaccines Major Product Offerings
  7.13.4 Onderstepoort Biological Brucellosis Vaccines Sales and Revenue in Global (2016-2021)
  7.13.5 Onderstepoort Biological Key News
7.14 Instituto Rosenbusch
  7.14.1 Instituto Rosenbusch Corporate Summary
  7.14.2 Instituto Rosenbusch Business Overview
  7.14.3 Instituto Rosenbusch Brucellosis Vaccines Major Product Offerings
  7.14.4 Instituto Rosenbusch Brucellosis Vaccines Sales and Revenue in Global (2016-2021)
  7.14.5 Instituto Rosenbusch Key News
7.15 Ceva Sante Animale
  7.15.1 Ceva Sante Animale Corporate Summary
  7.15.2 Ceva Sante Animale Business Overview
  7.15.3 Ceva Sante Animale Brucellosis Vaccines Major Product Offerings
  7.15.4 Ceva Sante Animale Brucellosis Vaccines Sales and Revenue in Global (2016-2021)
  7.15.5 Ceva Sante Animale Key News
7.16 Calier & Biologicos Laverlam
  7.16.1 Calier & Biologicos Laverlam Corporate Summary
  7.16.2 Calier & Biologicos Laverlam Business Overview
  7.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Major Product Offerings
  7.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Sales and Revenue in Global (2016-2021)
  7.16.5 Calier & Biologicos Laverlam Key News
7.17 Biovet
  7.17.1 Biovet Corporate Summary
  7.17.2 Biovet Business Overview
  7.17.3 Biovet Brucellosis Vaccines Major Product Offerings
  7.17.4 Biovet Brucellosis Vaccines Sales and Revenue in Global (2016-2021)
  7.17.5 Biovet Key News

8 GLOBAL BRUCELLOSIS VACCINES PRODUCTION CAPACITY, ANALYSIS

8.1 Global Brucellosis Vaccines Production Capacity, 2016-2027
8.2 Brucellosis Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Brucellosis Vaccines Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 BRUCELLOSIS VACCINES SUPPLY CHAIN ANALYSIS

10.1 Brucellosis Vaccines Industry Value Chain
10.2 Brucellosis Vaccines Upstream Market
10.3 Brucellosis Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Brucellosis Vaccines Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Brucellosis Vaccines in Global Market
Table 2. Top Brucellosis Vaccines Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Brucellosis Vaccines Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Brucellosis Vaccines Revenue Share by Companies, 2016-2021
Table 5. Global Brucellosis Vaccines Sales by Companies, (M Doses), 2016-2021
Table 6. Global Brucellosis Vaccines Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Brucellosis Vaccines Price (2016-2021) & (USD/K Doses)
Table 8. Global Manufacturers Brucellosis Vaccines Product Type
Table 9. List of Global Tier 1 Brucellosis Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brucellosis Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Brucellosis Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Brucellosis Vaccines Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Brucellosis Vaccines Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Brucellosis Vaccines Sales (M Doses), 2016-2021
Table 15. By Type - Global Brucellosis Vaccines Sales (M Doses), 2022-2027
Table 16. By Application – Global Brucellosis Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Brucellosis Vaccines Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Brucellosis Vaccines Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Brucellosis Vaccines Sales (M Doses), 2016-2021
Table 20. By Application - Global Brucellosis Vaccines Sales (M Doses), 2022-2027
Table 21. By Region – Global Brucellosis Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Brucellosis Vaccines Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Brucellosis Vaccines Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Brucellosis Vaccines Sales (M Doses), 2016-2021
Table 25. By Region - Global Brucellosis Vaccines Sales (M Doses), 2022-2027
Table 26. By Country - North America Brucellosis Vaccines Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Brucellosis Vaccines Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Brucellosis Vaccines Sales, (M Doses), 2016-2021
Table 29. By Country - North America Brucellosis Vaccines Sales, (M Doses), 2022-2027
Table 30. By Country - Europe Brucellosis Vaccines Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Brucellosis Vaccines Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Brucellosis Vaccines Sales, (M Doses), 2016-2021
Table 33. By Country - Europe Brucellosis Vaccines Sales, (M Doses), 2022-2027
Table 34. By Region - Asia Brucellosis Vaccines Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Brucellosis Vaccines Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Brucellosis Vaccines Sales, (M Doses), 2016-2021
Table 37. By Region - Asia Brucellosis Vaccines Sales, (M Doses), 2022-2027
Table 38. By Country - South America Brucellosis Vaccines Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Brucellosis Vaccines Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Brucellosis Vaccines Sales, (M Doses), 2016-2021
Table 41. By Country - South America Brucellosis Vaccines Sales, (M Doses), 2022-2027
Table 42. By Country - Middle East & Africa Brucellosis Vaccines Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Brucellosis Vaccines Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Brucellosis Vaccines Sales, (M Doses), 2016-2021
Table 45. By Country - Middle East & Africa Brucellosis Vaccines Sales, (M Doses), 2022-2027
Table 46. Jinyu Corporate Summary
Table 47. Jinyu Brucellosis Vaccines Product Offerings
Table 48. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 49. Colorado Serum Corporate Summary
Table 50. Colorado Serum Brucellosis Vaccines Product Offerings
Table 51. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 52. Boehringer Ingelheim Corporate Summary
Table 53. Boehringer Ingelheim Brucellosis Vaccines Product Offerings
Table 54. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 55. Biogenesis-Bago Corporate Summary
Table 56. Biogenesis-Bago Brucellosis Vaccines Product Offerings
Table 57. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 58. Vetal Company Corporate Summary
Table 59. Vetal Company Brucellosis Vaccines Product Offerings
Table 60. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 61. CZ Veterinaria Corporate Summary
Table 62. CZ Veterinaria Brucellosis Vaccines Product Offerings
Table 63. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 64. SYVA Laboratorios Corporate Summary
Table 65. SYVA Laboratorios Brucellosis Vaccines Product Offerings
Table 66. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 67. Indian Immunologicals Corporate Summary
Table 68. Indian Immunologicals Brucellosis Vaccines Product Offerings
Table 69. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 70. Qilu Corporate Summary
Table 71. Qilu Brucellosis Vaccines Product Offerings
Table 72. Qilu Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 73. Tecnovax Corporate Summary
Table 74. Tecnovax Brucellosis Vaccines Product Offerings
Table 75. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 76. Hester Biosciences Corporate Summary
Table 77. Hester Biosciences Brucellosis Vaccines Product Offerings
Table 78. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 79. Zoetis Corporate Summary
Table 80. Zoetis Brucellosis Vaccines Product Offerings
Table 81. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 82. Onderstepoort Biological Corporate Summary
Table 83. Onderstepoort Biological Brucellosis Vaccines Product Offerings
Table 84. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 85. Instituto Rosenbusch Corporate Summary
Table 86. Instituto Rosenbusch Brucellosis Vaccines Product Offerings
Table 87. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 88. Ceva Sante Animale Corporate Summary
Table 89. Ceva Sante Animale Brucellosis Vaccines Product Offerings
Table 90. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 91. Calier & Biologicos Laverlam Corporate Summary
Table 92. Calier & Biologicos Laverlam Brucellosis Vaccines Product Offerings
Table 93. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 94. Biovet Corporate Summary
Table 95. Biovet Brucellosis Vaccines Product Offerings
Table 96. Biovet Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 97. Brucellosis Vaccines Production Capacity (M Doses) of Key Manufacturers in Global Market, 2019-2021 (M Doses)
Table 98. Global Brucellosis Vaccines Capacity Market Share of Key Manufacturers, 2019-2021
Table 99. Global Brucellosis Vaccines Production by Region, 2016-2021 (M Doses)
Table 100. Global Brucellosis Vaccines Production by Region, 2022-2027 (M Doses)
Table 101. Brucellosis Vaccines Market Opportunities & Trends in Global Market
Table 102. Brucellosis Vaccines Market Drivers in Global Market
Table 103. Brucellosis Vaccines Market Restraints in Global Market
Table 104. Brucellosis Vaccines Raw Materials
Table 105. Brucellosis Vaccines Raw Materials Suppliers in Global Market
Table 106. Typical Brucellosis Vaccines Downstream
Table 107. Brucellosis Vaccines Downstream Clients in Global Market
Table 108. Brucellosis Vaccines Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Brucellosis Vaccines Segment by Type
Figure 2. Brucellosis Vaccines Segment by Application
Figure 3. Global Brucellosis Vaccines Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Brucellosis Vaccines Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Brucellosis Vaccines Revenue, 2016-2027 (US$, Mn)
Figure 7. Brucellosis Vaccines Sales in Global Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Brucellosis Vaccines Revenue in 2020
Figure 9. By Type - Global Brucellosis Vaccines Sales Market Share, 2016-2027
Figure 10. By Type - Global Brucellosis Vaccines Revenue Market Share, 2016-2027
Figure 11. By Type - Global Brucellosis Vaccines Price (USD/K Doses), 2016-2027
Figure 12. By Application - Global Brucellosis Vaccines Sales Market Share, 2016-2027
Figure 13. By Application - Global Brucellosis Vaccines Revenue Market Share, 2016-2027
Figure 14. By Application - Global Brucellosis Vaccines Price (USD/K Doses), 2016-2027
Figure 15. By Region - Global Brucellosis Vaccines Sales Market Share, 2016-2027
Figure 16. By Region - Global Brucellosis Vaccines Revenue Market Share, 2016-2027
Figure 17. By Country - North America Brucellosis Vaccines Revenue Market Share, 2016-2027
Figure 18. By Country - North America Brucellosis Vaccines Sales Market Share, 2016-2027
Figure 19. US Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Brucellosis Vaccines Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Brucellosis Vaccines Sales Market Share, 2016-2027
Figure 24. Germany Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 25. France Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Brucellosis Vaccines Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Brucellosis Vaccines Sales Market Share, 2016-2027
Figure 33. China Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 37. India Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Brucellosis Vaccines Revenue Market Share, 2016-2027
Figure 39. By Country - South America Brucellosis Vaccines Sales Market Share, 2016-2027
Figure 40. Brazil Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Brucellosis Vaccines Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Brucellosis Vaccines Sales Market Share, 2016-2027
Figure 44. Turkey Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Brucellosis Vaccines Revenue, (US$, Mn), 2016-2027
Figure 48. Global Brucellosis Vaccines Production Capacity (M Doses), 2016-2027
Figure 49. The Percentage of Production Brucellosis Vaccines by Region, 2020 VS 2027
Figure 50. Brucellosis Vaccines Industry Value Chain
Figure 51. Marketing Channels